Liposcale® is based on a high-performance technology that allows comprehensive analysis of the profile of lipoproteins present in the bloodstream. The information extracted from the profile of lipoproteins is essential in the clinic to diagnose the risk of CVD.
Liposcale® is recommended in:
The advanced lipoprotein test requires 0.5 ml of serum for the determination and physical measurement of the particles, including physical size and number of the different lipoprotein subclasses from 2-dimensional Nuclear Magnetic Resonance.
The Liposcale® medical software algorithm generates a report with a complete and exhaustive characterization of the lipoprotein profile:
In vitro diagnostic medical device with CE marking.
Available in USA. Marketed and distributed by Cima Sciences in the USA (https://cimasciences.com/).
Marketed and distributed in the rest of the world by Rubió Metabolomics (https://owlmetabolomics.com/).
For more information: liposcale@labrubio.com
Developed by: Biosfer Teslab, S.L.
Ownership: Biosfer Teslab, S.L.
The information contained in this area is directed exclusively to healthcare professionals with the capacity to prescribe or dispense medications.